Ca(2+)-stimulated adenylyl cyclases as therapeutic targets for psychiatric and neurodevelopmental disorders

Ca(2+)刺激的腺苷酸环化酶作为精神和神经发育障碍的治疗靶点

阅读:1

Abstract

As the main secondary messengers, cyclic AMP (cAMP) and Ca(2+) trigger intracellular signal transduction cascade and, in turn, regulate many aspects of cellular function in developing and mature neurons. The group I adenylyl cyclase (ADCY, also known as AC) isoforms, including ADCY1, 3, and 8 (also known as AC1, AC3, and AC8), are stimulated by Ca(2+) and thus functionally positioned to integrate cAMP and Ca(2+) signaling. Emerging lines of evidence have suggested the association of the Ca(2+)-stimulated ADCYs with bipolar disorder, schizophrenia, major depressive disorder, post-traumatic stress disorder, and autism. In this review, we discuss the molecular and cellular features as well as the physiological functions of ADCY1, 3, and 8. We further discuss the recent therapeutic development to target the Ca(2+)-stimulated ADCYs for potential treatments of psychiatric and neurodevelopmental disorders.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。